Clinical Presentation of Patients with Ebola Virus Disease in Conakry, Guinea
AuthorsBah, Elhadj Ibrahima
Jacob, Shevin T
Brett-Major, David M
Sall, Amadou Alpha
Fischer, William A
Saliou, Sow Mamadou
Bausch, Daniel G
Lawler, James V
Jacquerioz, Frederique A
Baggi, María F Méndez
Fowler, Robert A
MetadataShow full item record
AbstractBackground In March 2014, the World Health Organization was notified of an outbreak of Zaire ebolavirus in a remote area of Guinea. The outbreak then spread to the capital, Conakry, and to neighboring countries and has subsequently become the largest epidemic of Ebola virus disease (EVD) to date. Methods From March 25 to April 26, 2014, we performed a study of all patients with laboratory-confirmed EVD in Conakry. Mortality was the primary outcome. Secondary outcomes included patient characteristics, complications, treatments, and comparisons between survivors and nonsurvivors. Results Of 80 patients who presented with symptoms, 37 had laboratory-confirmed EVD. Among confirmed cases, the median age was 38 years (interquartile range, 28 to 46), 24 patients (65%) were men, and 14 (38%) were health care workers; among the health care workers, nosocomial transmission was implicated in 12 patients (32%). Patients with confirmed EVD presented to the hospital a median of 5 days (interquartile range, 3 to 7) after the onset of symptoms, most commonly with fever (in 84% of the patients; mean temperature, 38.6°C), fatigue (in 65%), diarrhea (in 62%), and tachycardia (mean heart rate, >93 beats per minute). Of these patients, 28 (76%) were treated with intravenous fluids and 37 (100%) with antibiotics. Sixteen patients (43%) died, with a median time from symptom onset to death of 8 days (interquartile range, 7 to 11). Patients who were 40 years of age or older, as compared with those under the age of 40 years, had a relative risk of death of 3.49 (95% confidence interval, 1.42 to 8.59; P=0.007). Conclusions Patients with EVD presented with evidence of dehydration associated with vomiting and severe diarrhea. Despite attempts at volume repletion, antimicrobial therapy, and limited laboratory services, the rate of death was 43%.
PublisherMassachusetts Medical Society
DescriptionTo access this article, click on "Additional Links".
- Ebola viral disease outbreak--West Africa, 2014.
- Authors: Dixon MG, Schafer IJ, Centers for Disease Control and Prevention (CDC).
- Issue date: 2014 Jun 27
- Ebola virus disease in children during the 2014-2015 epidemic in Guinea: a nationwide cohort study.
- Authors: Chérif MS, Koonrungsesomboon N, Kassé D, Cissé SD, Diallo SB, Chérif F, Camara F, Koné A, Avenido EF, Diakité M, Diallo MP, Le Gall E, Cissé M, Karbwang J, Hirayama K
- Issue date: 2017 Jun
- Multidisciplinary assessment of post-Ebola sequelae in Guinea (Postebogui): an observational cohort study.
- Authors: Etard JF, Sow MS, Leroy S, Touré A, Taverne B, Keita AK, Msellati P, Magassouba N, Baize S, Raoul H, Izard S, Kpamou C, March L, Savane I, Barry M, Delaporte E, Postebogui Study Group.
- Issue date: 2017 May
- Clinical profile and containment of the Ebola virus disease outbreak in two large West African cities, Nigeria, July-September 2014.
- Authors: Ohuabunwo C, Ameh C, Oduyebo O, Ahumibe A, Mutiu B, Olayinka A, Gbadamosi W, Garcia E, Nanclares C, Famiyesin W, Mohammed A, Nguku P, Koko RI, Obasanya J, Adebayo D, Gbadegesin Y, Idigbe O, Oguntimehin O, Nyanti S, Nzuki C, Abdus-Salam I, Adeyemi J, Onyekwere N, Musa E, Brett-Major D, Shuaib F, Nasidi A
- Issue date: 2016 Dec
- Clinical illness and outcomes in patients with Ebola in Sierra Leone.
- Authors: Schieffelin JS, Shaffer JG, Goba A, Gbakie M, Gire SK, Colubri A, Sealfon RS, Kanneh L, Moigboi A, Momoh M, Fullah M, Moses LM, Brown BL, Andersen KG, Winnicki S, Schaffner SF, Park DJ, Yozwiak NL, Jiang PP, Kargbo D, Jalloh S, Fonnie M, Sinnah V, French I, Kovoma A, Kamara FK, Tucker V, Konuwa E, Sellu J, Mustapha I, Foday M, Yillah M, Kanneh F, Saffa S, Massally JL, Boisen ML, Branco LM, Vandi MA, Grant DS, Happi C, Gevao SM, Fletcher TE, Fowler RA, Bausch DG, Sabeti PC, Khan SH, Garry RF, KGH Lassa Fever Program., Viral Hemorrhagic Fever Consortium., WHO Clinical Response Team.
- Issue date: 2014 Nov 27